Voyager Therapeutics (VYGR) EPS (Basic) (2014 - 2026)
Voyager Therapeutics' (VYGR) quarterly EPS (Basic) came in at -$0.47 in Q1 2026, up 11.32% year-on-year from -$0.42 in Q1 2025, and little changed quarter-over-quarter from -$0.47 in Q4 2025.
Voyager Therapeutics (VYGR) EPS (Basic) (2014 - 2026) Analysis & Trends
Voyager Therapeutics has disclosed EPS (Basic) across 13 years of filings, most recently posting -$0.47 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.47, up 11.32% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.98 (down 34.69% YoY), and the FY2025 annual result was -$2.04, down 80.53% from the prior year.
- EPS (Basic) came in at -$0.47 for Q1 2026 at Voyager Therapeutics, roughly flat from -$0.47 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $3.05 in Q1 2023 to a low of -$0.62 in Q4 2022.
- The 5-year median for EPS (Basic) is -$0.47 (2025), against an average of -$0.1.
- Across the five-year window, EPS (Basic) tumbled 513.33% in 2022 and surged 644.64% in 2023, its largest moves.
- Voyager Therapeutics' EPS (Basic) stood at -$0.62 in 2022, then jumped by 298.39% to $1.23 in 2023, then plunged by 148.78% to -$0.6 in 2024, then climbed by 21.67% to -$0.47 in 2025, then changed by 0.0% to -$0.47 in 2026.
- The last three EPS (Basic) figures came in at -$0.47 (Q1 2026), -$0.47 (Q4 2025), and -$0.47 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Voyager Therapeutics | 222.52 Mn | 81.04 Mn | - | -0.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.47 |
| Dec 31, 2025 | -0.47 |
| Sep 30, 2025 | -0.47 |
| Jun 30, 2025 | -0.57 |
| Mar 31, 2025 | -0.53 |
| Dec 31, 2024 | -0.60 |
| Sep 30, 2024 | -0.16 |
| Jun 30, 2024 | -0.18 |
| Mar 31, 2024 | -0.20 |
| Dec 31, 2023 | 1.23 |
| Sep 30, 2023 | -0.59 |
| Jun 30, 2023 | -0.51 |
| Mar 31, 2023 | 3.05 |
| Dec 31, 2022 | -0.62 |
| Sep 30, 2022 | 0.46 |
| Jun 30, 2022 | -0.50 |
| Mar 31, 2022 | -0.56 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | -0.67 |
| Jun 30, 2021 | -0.80 |